Your browser doesn't support javascript.
loading
Immunosuppression after pediatric liver transplant: The parents' perspective.
Batsis, Irini; Bucuvalas, John; Eisenberg, Elizabeth; Lau, Jennifer; Squires, James E; Feng, Sandy; Perito, Emily R.
Affiliation
  • Batsis I; Department of Pediatrics, Icahn School of Medicine, Kravis Children's Hospital at Mount Sinai, New York, New York, USA.
  • Bucuvalas J; Department of Pediatrics, Icahn School of Medicine, Kravis Children's Hospital at Mount Sinai, New York, New York, USA.
  • Eisenberg E; Patient and Family Voice, Starzl Network, Pittsburgh, Pennsylvania, USA.
  • Lau J; Patient and Family Engaged Partners, Society for Pediatric Liver Transplantation, Palo Alto, California, USA.
  • Squires JE; Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Feng S; Department of Pediatrics, San Francisco School of Medicine, University of California, San Francisco, California, USA.
  • Perito ER; Department of Pediatrics, San Francisco School of Medicine, University of California, San Francisco, California, USA.
Clin Transplant ; 37(4): e14931, 2023 04.
Article in En | MEDLINE | ID: mdl-36774540
ABSTRACT

BACKGROUND:

For children with liver transplants (LT), achieving an "ideal outcome" is a balancing act too little immunosuppression begets graft injury; too much begets systemic complications. We aimed to delineate the parental perspective on this tightrope.

METHODS:

Parents of children with LT completed an internet-based survey about their child's immunosuppression.

RESULTS:

Children of respondents (n = 82) were a median 4 years from primary LT (range 0-22); 73% were on immunosuppression monotherapy. Parents' top concerns were related to immunosuppression complications; 46% were more concerned about immunosuppression complications than rejection; only 17% were more concerned about rejection than immunosuppression complications. Among parents of children on immunosuppression monotherapy, 29% still worried more about immunosuppression complications than rejection, 48% expressed equal concern for both. Time since LT (0-4 vs. >4 years) was not associated with concern level for rejection or immunosuppression complications. Caregivers were significantly more certain that their child's immunosuppression regimen was correct to prevent rejection than to mitigate complications (p < .005).

CONCLUSION:

Caregivers of children with LTs reported higher levels of concern and uncertainty about immunosuppression complications than rejection risk. Understanding parent and patient perspectives on IS, and incorporating them into immunosuppression counseling and decision-making, is critical to achieving truly "ideal" long-term outcomes.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Liver Transplantation Type of study: Etiology_studies Limits: Child / Humans Language: En Journal: Clin Transplant Journal subject: TRANSPLANTE Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Liver Transplantation Type of study: Etiology_studies Limits: Child / Humans Language: En Journal: Clin Transplant Journal subject: TRANSPLANTE Year: 2023 Document type: Article Affiliation country: